{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T06:00:46Z","timestamp":1787032846481,"version":"build-2736575974"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,5,16]]},"DOI":"10.7759\/cureus.60426","type":"journal-article","created":{"date-parts":[[2024,5,16]],"date-time":"2024-05-16T09:09:16Z","timestamp":1715850556000},"source":"Crossref","is-referenced-by-count":3,"title":["Navigating Cardiovascular Risk in Type 1 Diabetes: A Comprehensive Review of Strategies for Prevention and Management"],"prefix":"10.7759","author":[{"given":"Shafaque","family":"Maqusood","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivek","family":"Chakole","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sambit","family":"Dash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1097\/POC.0000000000000125","article-title":"Type 1 diabetes - a clinical perspective","volume":"16","author":"Kahanovitz L","year":"2017","unstructured":"Kahanovitz L, Sluss PM, Russell SJ. Type 1 diabetes - a clinical perspective. Point Care. 2017, 16:37-40. 10.1097\/POC.0000000000000125","journal-title":"Point Care"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.4239\/wjd.v6.i13.1246","article-title":"Diabetes and cardiovascular disease: epidemiology, biological mechanisms, treatment recommendations and future research","volume":"6","author":"Leon BM","year":"2015","unstructured":"Leon BM, Maddox TM. Diabetes and cardiovascular disease: epidemiology, biological mechanisms, treatment recommendations and future research. World J Diabetes. 2015, 6:1246-58. 10.4239\/wjd.v6.i13.1246","journal-title":"World J Diabetes"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.43882","article-title":"Exploring the complex connection between diabetes and cardiovascular disease: analyzing approaches to mitigate cardiovascular risk in patients with diabetes","volume":"15","author":"Jyotsna F","year":"2023","unstructured":"Jyotsna F, Ahmed A, Kumar K, et al.. Exploring the complex connection between diabetes and cardiovascular disease: analyzing approaches to mitigate cardiovascular risk in patients with diabetes. Cureus. 2023, 15:e43882. 10.7759\/cureus.43882","journal-title":"Cureus"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1038\/nrcardio.2010.35","article-title":"Intensive glycemic control and cardiovascular disease: an update","volume":"7","author":"Brown A","year":"2010","unstructured":"Brown A, Reynolds LR, Bruemmer D. Intensive glycemic control and cardiovascular disease: an update. Nat Rev Cardiol. 2010, 7:369-75. 10.1038\/nrcardio.2010.35","journal-title":"Nat Rev Cardiol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-023-02112-y","article-title":"Glycemic control and cardiovascular outcomes in patients with diabetes and coronary artery disease according to triglyceride-glucose index: a large-scale cohort study","volume":"23","author":"Lin Z","year":"2024","unstructured":"Lin Z, He J, Yuan S, Song C, Bian X, Yang M, Dou K. Glycemic control and cardiovascular outcomes in patients with diabetes and coronary artery disease according to triglyceride-glucose index: a large-scale cohort study. Cardiovasc Diabetol. 2024, 23:11. 10.1186\/s12933-023-02112-y","journal-title":"Cardiovasc Diabetol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.165.16.1910","article-title":"Glycemic control and coronary heart disease risk in persons with and without diabetes: the atherosclerosis risk in communities study","volume":"165","author":"Selvin E","year":"2005","unstructured":"Selvin E, Coresh J, Golden SH, Brancati FL, Folsom AR, Steffes MW. Glycemic control and coronary heart disease risk in persons with and without diabetes: the atherosclerosis risk in communities study. Arch Intern Med. 2005, 165:1910-6. 10.1001\/archinte.165.16.1910","journal-title":"Arch Intern Med"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics15071791","article-title":"Impact of intensive glycemic treatment on diabetes complications-a systematic review","volume":"15","author":"Poonoosamy J","year":"2023","unstructured":"Poonoosamy J, Lopes P, Huret P, Dardari R, Penfornis A, Thomas C, Dardari D. Impact of intensive glycemic treatment on diabetes complications-a systematic review. Pharmaceutics. 2023, 15:1791. 10.3390\/pharmaceutics15071791","journal-title":"Pharmaceutics"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.2337\/dc08-1775","article-title":"Lipid and lipoprotein profiles in youth with and without type 1 diabetes: the SEARCH for Diabetes in Youth case-control study","volume":"32","author":"Guy J","year":"2009","unstructured":"Guy J, Ogden L, Wadwa RP, et al.. Lipid and lipoprotein profiles in youth with and without type 1 diabetes: the SEARCH for Diabetes in Youth case-control study. Diabetes Care. 2009, 32:416-20. 10.2337\/dc08-1775","journal-title":"Diabetes Care"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-020-01099-0","article-title":"Advanced lipoprotein profile disturbances in type 1 diabetes mellitus: a focus on LDL particles","volume":"19","author":"Amor AJ","year":"2020","unstructured":"Amor AJ, Castelblanco E, Hern\u00e1ndez M, et al.. Advanced lipoprotein profile disturbances in type 1 diabetes mellitus: a focus on LDL particles. Cardiovasc Diabetol. 2020, 19:126. 10.1186\/s12933-020-01099-0","journal-title":"Cardiovasc Diabetol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1097\/XCE.0000000000000169","article-title":"The early detection of atherosclerosis in type 1 diabetes: why, how and what to do about it","volume":"8","author":"Jenkins A","year":"2019","unstructured":"Jenkins A, Januszewski A, O'Neal D. The early detection of atherosclerosis in type 1 diabetes: why, how and what to do about it. Cardiovasc Endocrinol Metab. 2019, 8:14-27. 10.1097\/XCE.0000000000000169","journal-title":"Cardiovasc Endocrinol Metab"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1080\/14656566.2020.1729124","article-title":"Treatment strategies for hypertension in patients with type 1 diabetes","volume":"21","author":"Katsimardou A","year":"2020","unstructured":"Katsimardou A, Imprialos K, Stavropoulos K, Sachinidis A, Doumas M, Athyros VG. Treatment strategies for hypertension in patients with type 1 diabetes. Expert Opin Pharmacother. 2020, 21:1241-52. 10.1080\/14656566.2020.1729124","journal-title":"Expert Opin Pharmacother"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1136\/bmjdrc-2022-002765","article-title":"Cardiovascular risk management in people with type 1 diabetes: performance using three guidelines","volume":"10","author":"Varkevisser RD","year":"2022","unstructured":"Varkevisser RD, Birnie E, Vollenbrock CE, et al.. Cardiovascular risk management in people with type 1 diabetes: performance using three guidelines. BMJ Open Diabetes Res Care. 2022, 10:10.1136\/bmjdrc-2022-002765","journal-title":"BMJ Open Diabetes Res Care"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.42616","article-title":"Impact of lifestyle modifications on cardiovascular health: a narrative review","volume":"15","author":"Ghodeshwar GK","year":"2023","unstructured":"Ghodeshwar GK, Dube A, Khobragade D. Impact of lifestyle modifications on cardiovascular health: a narrative review. Cureus. 2023, 15:e42616. 10.7759\/cureus.42616","journal-title":"Cureus"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.4103\/2230-8210.86982","article-title":"Management of diabetic hypertensives","volume":"15","author":"Ganesh J","year":"2011","unstructured":"Ganesh J, Viswanathan V. Management of diabetic hypertensives. Indian J Endocrinol Metab. 2011, 15:S374-9. 10.4103\/2230-8210.86982","journal-title":"Indian J Endocrinol Metab"},{"key":"ref15","unstructured":"High blood pressure. (2015). Accessed. April 17, 2024: https:\/\/www.nice.org.uk\/guidance\/ng17\/ifp\/chapter\/high-blood-pressure."},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1097\/XCE.0000000000000167","article-title":"Cardiovascular disease in type 1 diabetes","volume":"8","author":"Sharma H","year":"2019","unstructured":"Sharma H, Lencioni M, Narendran P. Cardiovascular disease in type 1 diabetes. Cardiovasc Endocrinol Metab. 2019, 8:28-34. 10.1097\/XCE.0000000000000167","journal-title":"Cardiovasc Endocrinol Metab"},{"key":"ref17","unstructured":"Type 1 diabetes diet plan, recommendations, foods to eat and avoid. Accessed. April 21, 2024: https:\/\/www.medicinenet.com\/type_1_diabetes_diet\/article.htm."},{"key":"ref18","unstructured":"Type 1 diabetes diet. what foods to eat, why it\u2019s important, and more. (2018). Accessed: April 21, 2024: https:\/\/www.healthline.com\/health\/type-1-diabetes-diet."},{"key":"ref19","unstructured":"What is a type 1 diabetes diet?. (2020). Accessed. April 17, 2024: https:\/\/www.medicalnewstoday.com\/articles\/type-1-diabetes-diet."},{"key":"ref20","unstructured":"Exercise & type 1. Accessed. April 17, 2024: https:\/\/diabetes.org\/health-wellness\/fitness\/exercise-and-type-1."},{"key":"ref21","unstructured":"Exercising with type 1 diabetes. how to work out and stay safe. (2021). Accessed: April 17, 2024: https:\/\/www.healthline.com\/health\/severe-hypoglycemia\/working-out."},{"key":"ref22","unstructured":"Exercise and type 1 diabetes. keeping sugar levels under control. Accessed: April 17, 2024: https:\/\/www.diabinfo.de\/en\/living-with-diabetes\/type-1-diabetes\/diabetes-in-everyday-life\/exercise.html."},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1177\/1932296814566231","article-title":"Physical activity and type 1 diabetes: time for a rewire?","volume":"9","author":"Colberg SR","year":"2015","unstructured":"Colberg SR, Laan R, Dassau E, Kerr D. Physical activity and type 1 diabetes: time for a rewire?. J Diabetes Sci Technol. 2015, 9:609-18. 10.1177\/1932296814566231","journal-title":"J Diabetes Sci Technol"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1007\/s11892-017-0918-8","article-title":"Weight management in patients with type 1 diabetes and obesity","volume":"17","author":"Mottalib A","year":"2017","unstructured":"Mottalib A, Kasetty M, Mar JY, Elseaidy T, Ashrafzadeh S, Hamdy O. Weight management in patients with type 1 diabetes and obesity. Curr Diab Rep. 2017, 17:92. 10.1007\/s11892-017-0918-8","journal-title":"Curr Diab Rep"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1210\/er.2017-00191","article-title":"Obesity in type 1 diabetes: pathophysiology, clinical impact, and mechanisms","volume":"39","author":"Corbin KD","year":"2018","unstructured":"Corbin KD, Driscoll KA, Pratley RE, Smith SR, Maahs DM, Mayer-Davis EJ. Obesity in type 1 diabetes: pathophysiology, clinical impact, and mechanisms. Endocr Rev. 2018, 39:629-63. 10.1210\/er.2017-00191","journal-title":"Endocr Rev"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1016\/j.endien.2017.05.003","article-title":"Tobacco and diabetes: clinical relevance and approach to smoking cessation in diabetic smokers","volume":"64","author":"L\u00f3pez Zubizarreta M","year":"2017","unstructured":"L\u00f3pez Zubizarreta M, Hern\u00e1ndez Mezquita M\u00c1, Miralles Garc\u00eda JM, Barrueco Ferrero M. Tobacco and diabetes: clinical relevance and approach to smoking cessation in diabetic smokers. Endocrinol Diabetes Nutr. 2017, 64:221-31. 10.1016\/j.endien.2017.05.003","journal-title":"Endocrinol Diabetes Nutr"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.4239\/wjd.v13.i6.422","article-title":"Impact of stopping smoking on metabolic parameters in diabetes mellitus: a scoping review","volume":"13","author":"Walicka M","year":"2022","unstructured":"Walicka M, Russo C, Baxter M, John I, Caci G, Polosa R. Impact of stopping smoking on metabolic parameters in diabetes mellitus: a scoping review. World J Diabetes. 2022, 13:422-33. 10.4239\/wjd.v13.i6.422","journal-title":"World J Diabetes"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.18332\/tpc\/181366","article-title":"Exploring the smoking cessation needs of individuals with diabetes using the Information-Motivation-Behavior Skills model","volume":"10","author":"Grech J","year":"2024","unstructured":"Grech J, Norman IJ, Sammut R. Exploring the smoking cessation needs of individuals with diabetes using the Information-Motivation-Behavior Skills model. Tob Prev Cessat. 2024, 10:1-13. 10.18332\/tpc\/181366","journal-title":"Tob Prev Cessat"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1186\/1475-2840-12-156","article-title":"Type 1 diabetes and cardiovascular disease","volume":"12","author":"Schnell O","year":"2013","unstructured":"Schnell O, Cappuccio F, Genovese S, Standl E, Valensi P, Ceriello A. Type 1 diabetes and cardiovascular disease. Cardiovasc Diabetol. 2013, 12:156. 10.1186\/1475-2840-12-156","journal-title":"Cardiovasc Diabetol"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1007\/s13300-019-0612-8","article-title":"Cardiovascular risk in type 1 diabetes mellitus","volume":"10","author":"Schofield J","year":"2019","unstructured":"Schofield J, Ho J, Soran H. Cardiovascular risk in type 1 diabetes mellitus. Diabetes Ther. 2019, 10:773-89. 10.1007\/s13300-019-0612-8","journal-title":"Diabetes Ther"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10081798","article-title":"Cardiovascular disease in type 1 diabetes mellitus: epidemiology and management of cardiovascular risk","volume":"10","author":"Colom C","year":"2021","unstructured":"Colom C, Rull A, Sanchez-Quesada JL, P\u00e9rez A. Cardiovascular disease in type 1 diabetes mellitus: epidemiology and management of cardiovascular risk. J Clin Med. 2021, 10:1798. 10.3390\/jcm10081798","journal-title":"J Clin Med"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.2337\/dc15-S011","article-title":"Cardiovascular disease and risk management","volume":"38","author":"American Diabetes Association","year":"2015","unstructured":"American Diabetes Association. Cardiovascular disease and risk management. Diabetes Care. 2015, 38:S49-57. 10.2337\/dc15-S011","journal-title":"Diabetes Care"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2021.696499","article-title":"Preventing cardiovascular complications in type 1 diabetes: the need for a lifetime approach","volume":"9","author":"Chiesa ST","year":"2021","unstructured":"Chiesa ST, Marcovecchio ML. Preventing cardiovascular complications in type 1 diabetes: the need for a lifetime approach. Front Pediatr. 2021, 9:696499. 10.3389\/fped.2021.696499","journal-title":"Front Pediatr"},{"key":"ref34","unstructured":"What angel number 111 is actually trying to tell you and what to do about it. (2023). Accessed. April 21, 2024: https:\/\/www.mindbodygreen.com\/articles\/111-angel-number."},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000000034","article-title":"Type 1 diabetes mellitus and cardiovascular disease: a scientific statement from the American Heart Association and American Diabetes Association","volume":"130","author":"de Ferranti SD","year":"2014","unstructured":"de Ferranti SD, de Boer IH, Fonseca V, et al.. Type 1 diabetes mellitus and cardiovascular disease: a scientific statement from the American Heart Association and American Diabetes Association. Circulation. 2014, 130:1110-30. 10.1161\/CIR.0000000000000034","journal-title":"Circulation"},{"key":"ref36","unstructured":"Shared decision-making. Accessed. April 17, 2024: https:\/\/www.england.nhs.uk\/personalisedcare\/shared-decision-making\/."},{"key":"ref37","unstructured":"Shared decision making. Accessed. April 21, 2024: https:\/\/www.nice.org.uk\/about\/what-we-do\/our-programmes\/nice-guidance\/nice-guidelines\/shared-decision-making."},{"key":"ref38","unstructured":"Shared decision making | Australian Commission on Safety and Quality in Health Care. (2024). Accessed. April 21, 2024: https:\/\/www.safetyandquality.gov.au\/our-work\/partnering-consumers\/shared-decision-making."},{"key":"ref39","article-title":"Shared decision making in preventive health care: what it is; what it is not","volume":"63","author":"Grad R","year":"2017","unstructured":"Grad R, L\u00e9gar\u00e9 F, Bell NR, et al.. Shared decision making in preventive health care: what it is; what it is not. Can Fam Physician. 2017, 63:682-4.","journal-title":"Can Fam Physician"},{"key":"ref40","unstructured":"The publics\u2019 perspective on cardiovascular risk information. implications for practice. (2021). Accessed: April 21, 2024: https:\/\/uu.diva-portal.org\/smash\/record.jsf?pid=diva2%3A1509397&dswid=5542."},{"key":"ref41","article-title":"Patient education and empowerment","author":"Funnell MM","year":"2018","unstructured":"Funnell MM, Anderson RM, Piatt GA. Patient education and empowerment. Diabetes epidemiology, genetics, pathogenesis, diagnosis, prevention, and treatment. Bonora E, DeFronzo R (ed): Springer International Publishing, Cham, Switzerland; 2018. 485-96."},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1159\/000535051","article-title":"Psychosocial factors and the role of family in children with type 1 diabetes mellitus","volume":"29","author":"Soodhana Mohan D","year":"2023","unstructured":"Soodhana Mohan D, HN V, Madegowda RK, Palany R. Psychosocial factors and the role of family in children with type 1 diabetes mellitus. Dubai Diabetes Endocrinol J. 2023, 29:171-8. 10.1159\/000535051","journal-title":"Dubai Diabetes Endocrinol J"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.2337\/dc16-2053","article-title":"Psychosocial care for people with diabetes: a position statement of the American Diabetes Association","volume":"39","author":"Young-Hyman D","year":"2016","unstructured":"Young-Hyman D, de Groot M, Hill-Briggs F, Gonzalez JS, Hood K, Peyrot M. Psychosocial care for people with diabetes: a position statement of the American Diabetes Association. Diabetes Care. 2016, 39:2126-40. 10.2337\/dc16-2053","journal-title":"Diabetes Care"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.119.310961","article-title":"Diabetes mellitus and cardiovascular disease","volume":"39","author":"Schmidt AM","year":"2019","unstructured":"Schmidt AM. Diabetes mellitus and cardiovascular disease. Arterioscler Thromb Vasc Biol. 2019, 39:558-68. 10.1161\/ATVBAHA.119.310961","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.3390\/life14010099","article-title":"Novel therapeutic agents for management of diabetes mellitus: a hope for drug designing against diabetes mellitus","volume":"14","author":"Elkhalifa AM","year":"2024","unstructured":"Elkhalifa AM, Nazar M, Ali SI, et al.. Novel therapeutic agents for management of diabetes mellitus: a hope for drug designing against diabetes mellitus. Life (Basel). 2024, 14:99. 10.3390\/life14010099","journal-title":"Life (Basel)"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-022-01692-5","article-title":"Time trends of cardiovascular risk management in type 1 diabetes\u00a0-\u00a0nationwide analyses of real-life data","volume":"21","author":"Amadid H","year":"2022","unstructured":"Amadid H, Clemmensen KK, Vistisen D, Persson F, J\u00f8rgensen ME. Time trends of cardiovascular risk management in type 1 diabetes\u00a0-\u00a0nationwide analyses of real-life data. Cardiovasc Diabetol. 2022, 21:255. 10.1186\/s12933-022-01692-5","journal-title":"Cardiovasc Diabetol"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1007\/s41745-023-00356-x","article-title":"Precision medicine in type 1 diabetes","volume":"103","author":"Michalek DA","year":"2023","unstructured":"Michalek DA, Onengut-Gumuscu S, Repaske DR, Rich SS. Precision medicine in type 1 diabetes. J Indian Inst Sci. 2023, 103:335-51. 10.1007\/s41745-023-00356-x","journal-title":"J Indian Inst Sci"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1038\/s43856-023-00429-z","article-title":"Precision prognostics for cardiovascular disease in type 2 diabetes: a systematic review and meta-analysis","volume":"4","author":"Ahmad A","year":"2024","unstructured":"Ahmad A, Lim LL, Morieri ML, et al.. Precision prognostics for cardiovascular disease in type 2 diabetes: a systematic review and meta-analysis. Commun Med (Lond). 2024, 4:11. 10.1038\/s43856-023-00429-z","journal-title":"Commun Med (Lond)"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1002\/hsr2.1642","article-title":"Transform diabetes care with precision medicine","volume":"6","author":"Kannan S","year":"2023","unstructured":"Kannan S, Chellappan DK, Kow CS, et al.. Transform diabetes care with precision medicine. Health Sci Rep. 2023, 6:e1642. 10.1002\/hsr2.1642","journal-title":"Health Sci Rep"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.5694\/mja2.50946","article-title":"Technologies in the management of type 1 diabetes","volume":"214","author":"Snaith JR","year":"2021","unstructured":"Snaith JR, Holmes-Walker DJ. Technologies in the management of type 1 diabetes. Med J Aust. 2021, 214:202-5. 10.5694\/mja2.50946","journal-title":"Med J Aust"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(19)31142-0","article-title":"Advances in technology for management of type 1 diabetes","volume":"394","author":"Beck RW","year":"2019","unstructured":"Beck RW, Bergenstal RM, Laffel LM, Pickup JC. Advances in technology for management of type 1 diabetes. Lancet. 2019, 394:1265-73. 10.1016\/s0140-6736(19)31142-0","journal-title":"Lancet"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.3390\/life13081663","article-title":"Current technologies for managing type 1 diabetes mellitus and their impact on quality of life\u2014a narrative review","volume":"13","author":"Elian V","year":"2023","unstructured":"Elian V, Popovici V, Ozon EA, et al.. Current technologies for managing type 1 diabetes mellitus and their impact on quality of life\u2014a narrative review. Life (Basel). 2023, 13:1663. 10.3390\/life13081663","journal-title":"Life (Basel)"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.1016\/j.ecl.2020.07.006","article-title":"New and emerging technologies in type 1 diabetes","volume":"49","author":"Sherwood JS","year":"2020","unstructured":"Sherwood JS, Russell SJ, Putman MS. New and emerging technologies in type 1 diabetes. Endocrinol Metab Clin North Am. 2020, 49:667-78. 10.1016\/j.ecl.2020.07.006","journal-title":"Endocrinol Metab Clin North Am"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/251874-navigating-cardiovascular-risk-in-type-1-diabetes-a-comprehensive-review-of-strategies-for-prevention-and-management","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,16]],"date-time":"2024-05-16T09:09:29Z","timestamp":1715850569000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/251874-navigating-cardiovascular-risk-in-type-1-diabetes-a-comprehensive-review-of-strategies-for-prevention-and-management"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,16]]},"references-count":53,"URL":"https:\/\/doi.org\/10.7759\/cureus.60426","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5,16]]}}}